Skip to main content
. 2010 Aug;33(8):1865–1871. doi: 10.2337/dc10-0641

Figure 4.

Figure 4

Plasma biomarkers of endothelial dysfunction predict both type 2 diabetes (T2D) and CVD. A: Shows the 7-year cumulative incidence of type 2 diabetes by quartile (Q1-Q4) of plasminogen activator inhibitor-1 (PAI-1) or von Willebrand factor (vWF). The type 2 diabetes–risk factor adjusted relative risk (RR) for type 2 diabetes per interquartile (IQR) increase in vWF was 1.4 (95% CI 1.1–1.8, P = 0.009) (adapted from Meigs et al. [21]). B: Shows survival free of CVD events in FHS as a function of the presence or absence of type 2 diabetes and by low (Q1-Q3) or high (Q4) levels of vWF. Risk of CVD is increased in individuals with elevated levels of vWF, especially in individuals with type 2 diabetes and elevated vWF (P < 0.0001) (adapted from Frankel et al. [22]). DM, diabetes mellitus.